GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Isis Pharmaceuticals, Inc. (ISIS) [hlAlert]

Rating:
Buy ISIS
up 264.89 %

Isis Pharmaceuticals, Inc. (ISIS) rated Buy

Posted on: Friday,  Sep 14, 2007  11:25 AM ET by BWS Financial

BWS Financial rated Buy Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) on 09/14/2007, when the stock price was $14.13. Since
then, Isis Pharmaceuticals, Inc. has gained 264.90% as of 11/10/2015's recent price of $51.56.
If you would have followed this BWS Financial's recommendation on ISIS, you would have gained 264.89% of your investment in 2979 days.

Isis Pharmaceuticals, Inc. (Isis) is engaged in antisense technology, exploiting a drug discovery platform to create a pipeline of drugs. The Company operates in a two principal segments: Drug Discovery and Development and Regulus Therapeutics Inc. Within the Drug Discovery and Development segment, its drug discovery platform enables the Company to identify drugs, providing potential targets to treat a range of diseases. As of December 31, 2008, the Company has 19 drugs in development. Its partners are licensed to develop, with the Company?s support, 15 of these 19 drugs. The Company and Alnylam established Regulus Therapeutics Inc. as a company focused on the discovery, development and commercialization of microRNA therapeutics. In January 2009, the Company sold its subsidiary, Ibis Biosciences, Inc. to Abbott Molecular Inc. (AMI), a wholly owned subsidiary of Abbott Laboratories.

· BWS Financial is a Los Angeles based independent stock research firm, which focuses primarily on undervalued companies with little or no street coverage, within the biotechnology, healthcare and technology industries. · BWS Financial focuses on companies that hold much potential in their industries, either through their product pipeline or technological innovations. · BWS Financial’s strategy is not to only specialize in a particular group of stocks, but to also provide investors with insight into other ideas where there is considerable misvaluation.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/14/2007 11:25 AM Buy
None
14.13 20.00
as of 8/27/2015
1 Week up  3.65 %
1 Month down  -19.38 %
3 Months down  -17.43 %
1 YTD up  29.41 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy